Alendronate: all 89 studies that test it

Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing ChemoradiationNot yet recruitingNCT07245381Phase 1/2
• Small Trial of Alendronate Impact on the Reservoir of HIVRecruitingNCT07216794Phase 2
• A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without FracturesRecruitingNCT06864130Phase 4
• Precision Medicine Approach for Osteoporosis - Follow Up StudyEnrolling by invitationNCT06264609Phase 4
• Alendronate for Osteonecrosis in Adults With Sickle Cell DiseaseRecruitingNCT06016634Phase 2
• A Multi-centre, Double-blind RCT to Investigate the Effect of Alendronate on Knee Function Following ACLRRecruitingNCT05527548Phase 4
• Bisphosphonates for Prevention of Post-Denosumab Bone LossCompletedNCT03396315Phase 2Results posted
• Renal Osteodystrophy: An Individual Management ApproachCompletedNCT02440581Not applicableResults posted
• Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis TreatmentCompletedNCT02371252Phase 4Results posted
• Alendronate to Prevent Loss of Bronchoprotection in AsthmaCompletedNCT02230332Phase 2/3Results posted
• Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With TeriparatideCompletedNCT02195895Phase 2Results posted
• Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot StudyCompletedNCT02139007Phase 4Results posted
• Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone ResorptionCompletedNCT01750086Phase 4Results posted
• Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With OsteoporosisCompletedNCT01657162Phase 3Results posted
• Stem Cell Recruitment in Osteoporosis TherapyTerminatedNCT01656629Not applicableResults posted
• Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term TherapyTerminatedNCT01512446Phase 3Results posted
• Testosterone and Alendronate in Hypogonadal MenTerminatedNCT01460654Phase 2Results posted
• Pilot Study of Fosamax in Spinal Cord InjuryTerminatedNCT01131884Not applicableResults posted
• Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and AdolescentsCompletedNCT00921557Phase 2Results posted
• Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.CompletedNCT00835406Phase 1Results posted
• A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin DCompletedNCT00806416Phase 1Results posted
• A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)CompletedNCT00803790Phase 1Results posted
• The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)TerminatedNCT00713258Phase 4Results posted
• Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas TransplantsCompletedNCT00580047Not applicableResults posted
• Denosumab Adherence Preference Satisfaction StudyCompletedNCT00518531Phase 3Results posted
• Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal WomenCompletedNCT00504166Phase 4Results posted
• Secondary Prevention of OsteoporosisCompletedNCT00421343Phase 3Results posted
• Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ TransplantationCompletedNCT00297830Phase 2/3Results posted
• Safety and Efficacy of Alendronate (Fosamax) in Children With OsteoporosisCompletedNCT00259857Phase 2Results posted
• Bisphosphonate Therapy for Osteogenesis ImperfectaCompletedNCT00159419Phase 4Results posted
• Texture Analysis for Postmenopausal OsteoporosisCompletedNCT00145977Not applicableResults posted
• Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile OsteoporosisCompletedNCT00010439Phase 2Results posted
• Clinical Efficacy of 1% Metformin and Alendronate Gel in Adjunct to Fibrin in Chronic PeriodontitisActive, not recruitingNCT06856369Phase 4
• A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)CompletedNCT06772792Phase 1
• Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone TurnoverActive, not recruitingNCT05151484Phase 4
• The Optimal Sequential Therapy After Long Term Denosumab TreatmentCompletedNCT05091099Phase 4
• Alendronate Versus Denosumab in Kidney Transplant PatientsCompletedNCT04169698Phase 2/3
• Comparative Antiresorptive Efficacy Discontinuation of DenosumabActive, not recruitingNCT03623633Phase 4
• Local Host Modulating Agents Alendronate & Aloe Vera for Treatment of Furcation Defects in Chronic PeriodontitisCompletedNCT03204097Phase 2/3
• Alendronate Treatment of Osteoporosis in Rheumatoid ArthritisCompletedNCT02944799Phase 2
• Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects.CompletedNCT02795546Phase 4
• Pilot Study of Bisphosphonates for Breast CancerTerminatedNCT02781805Phase 1
• A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal OsteoporosisCompletedNCT02598440Phase 4
• Sodium Alendronate in Non Surgical Periodontal TherapyCompletedNCT02470611Phase 4
• Alendronate for Prevention of AntiRetroviral Therapy-associated Bone LossTerminatedNCT02322099Phase 4
• Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis ImperfectaCompletedNCT02303873Phase 4
• 1% Alendronate Gel in Treatment of Chronic Periodontitis Among SmokersCompletedNCT02168543Phase 2
• Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.CompletedNCT02132026Phase 2
• The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy AdultsCompletedNCT02057263Phase 1
• Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot TrialCompletedNCT01968850Phase 2
• OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary HyperparathyroidismCompletedNCT01889134Not applicable
• Treatment of Low Bone Density in Cystic Fibrosis.CompletedNCT01812551Phase 3
• Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal OsteoporosisCompletedNCT01535027Phase 4
• The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)Status unknownNCT01020253Not applicable
• Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With OsteoporosisCompletedNCT00936260Not applicable
• Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral PalsyTerminatedNCT00822029Phase 3
• Biorest Liposomal Alendronate With Stenting sTudy (BLAST)CompletedNCT00739466Phase 2
• Cyclic Versus Daily Teriparatide on Bone MassStatus unknownNCT00668941Phase 2
• Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential EffectsCompletedNCT00666627Phase 2
• Bone Health in Gynecologic Cancers-does FOSAVANCE Help?CompletedNCT00593580Phase 2
• A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)CompletedNCT00480662Phase 3
• Osteoporosis Prevention With Low Dose AlendronateCompletedNCT00463268Phase 3
• Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney DiseaseCompletedNCT00395382Phase 4
• Fosamax for Childhood Cancer SurvivorsStatus unknownNCT00391404Phase 3
• The Effects of Alendronate After Cure of Primary HyperparathyroidismWithdrawnNCT00359385Phase 4
• The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.Status unknownNCT00346190Phase 3
• Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly AlendronateCompletedNCT00327990Phase 4
• Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?Status unknownNCT00299572Phase 4
• Alendronate Osteoporosis StudyCompletedNCT00277251Phase 2/3
• Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic OsteonecrosisStatus unknownNCT00265252Phase 4
• Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?CompletedNCT00261625Phase 4
• Network Osteoporosis StudyStatus unknownNCT00209469Phase 2/3
• Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)CompletedNCT00177619Phase 3
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis PatientsCompletedNCT00157690Phase 4
• Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm AssessmentCompletedNCT00122356Phase 3
• Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)CompletedNCT00120757Phase 3
• A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)CompletedNCT00092014Phase 3
• The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected PatientsCompletedNCT00061256Phase 2
• Prevention of Osteoporosis in Men With Prostate CancerCompletedNCT00048841Phase 3
• Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate CancerTerminatedNCT00019695Phase 2
• Bone Loss in Premenopausal Women With DepressionCompletedNCT00006180Phase 4
• PaTH Study: Parathyroid Hormone and Alendronate for OsteoporosisCompletedNCT00005005Phase 2
• Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related OsteoporosisCompletedNCT00004489Not applicable
• Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's DiseaseCompletedNCT00004488Phase 2
• Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright SyndromeCompletedNCT00001728Phase 2
• Treatment of Childhood Osteoporosis With Alendronate (Fosamax)CompletedNCT00001720Phase 2
• Low-Dose Hormone Replacement Therapy and Alendronate for OsteoporosisTerminatedNCT00000430Phase 3
• Osteoporosis Prevention After Heart TransplantCompletedNCT00000412Phase 3
• Alendronate and/or Parathyroid Hormone for OsteoporosisCompletedNCT00000400Phase 2

← Alendronate overview